Awards & Honors – Feb 27, 2017
Goldman Receives Breast Cancer Alliance Young Investigator Award
Aaron Goldman, PhD
Aaron Goldman, PhD, associate bioengineer in the Division of Biomedical Engineering, was named a recipient of the Breast Cancer Alliance Young Investigator Award, which honors early-career clinicians and researchers committed to the study of breast cancer.
The award’s two-year, $125,000 grant will fund Goldman’s project, “HCK (Hemopoetic Cell Kinase)-Disruptive Nanomedicines to Overcome Treatment Resistance in Triple Negative Breast Cancer.”
Goldman’s lab studies mechanisms that drive resistance to cancer therapy, working to identify unique proteins that cause this resistance and looking for new ways to target them. His research team was among the first to identify that drug resistance can occur as a consequence of cancer cells being treated with chemotherapy.
The Breast Cancer Alliance is dedicated to improving survival rates and quality of life for those affected by breast cancer by identifying better ways to prevent, detect, treat and cure the disease.